Albert David Limited Share Price NSE India S.E.

ALBERTDAVD

INE155C01010

Pharmaceuticals

Delayed NSE India S.E. 02:33:50 02/09/2026 pm IST			5-day change	1st Jan Change
872.05 ^INR	+0.04%		+0.27%	+18.39%

06/08	Albert David Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
06/08	Albert David Limited Approves Appointment of Mr. Amit Mahla as Whole-Time Director, effective 19 June, 2026	CI

Valuation : Albert David Limited

Market Cap	496.61Cr 5.23Cr 4.51Cr 4.25Cr 3.87Cr 7.27Cr 7.31Cr 50Cr 20Cr 252.61Cr 20Cr 19Cr 837.63Cr	P/E 2025	26.9x	P/E 2026	-224x
Enterprise Value	268.61Cr 2.83Cr 2.44Cr 2.3Cr 2.09Cr 3.93Cr 3.96Cr 27Cr 11Cr 136.63Cr 11Cr 10Cr 453.05Cr	EV / Sales 2025	0.67x	EV / Sales 2026	0.32x
Free-Float	35.96%	Yield 2025	0.62%	Yield 2026	0.85%

* Estimated data More valuation ratios

Latest news : Albert David Limited

06/08	Albert David Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
06/08	Albert David Limited Approves Appointment of Mr. Amit Mahla as Whole-Time Director, effective 19 June, 2026	CI
06/08	Albert David Limited Announces Resignation of Kuntal Ganguly from Head- R&D, Effective August 5, 2026	CI
30/05	Albert David Limited Announces Resignation of Chandra Bhushan Thakur from Head-Operations, Effective May 29, 2026	CI
12/05	Albert David appoints Amit Mahla as CEO effective May 12	RE
12/05	Albert David Limited Announces Appointment of Amit Mahla as the Chief Executive Officer with Effect from May 12, 2026	CI
12/05	Albert David Limited Announces Appointment of Amit Mahla as the Key Managerial Personnel with Effect from May 12, 2026	CI
12/05	Albert David Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
12/05	Albert David Limited announces Annual dividend, payable on September 05, 2026	CI
11/02	Albert David Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
19/12	Albert David says Umesh Manohar Kunte resigns as MD, CEO	RE
18/12	Albert David says Umesh Manohar Kunte resigns as managing director and CEO	RE
18/12	Albert David Limited Announces Resignation of CEO Umesh Manohar Kunte, Effective December 18, 2025	CI

More news

Managers and Directors : Albert David Limited

Manager	Title	Age	Since
Amit Mahla CEO	Chief Executive Officer	52	12/05/2026
Ranadeep Bhattacharya DFI	Director of Finance/CFO	-	01/12/2020
Lalit Lohia CMP	Compliance Officer	-	-

Director	Title	Age	Since
Arun Kumar Kothari CHM	Chairman	73	30/12/2009
Prabhawati Devi Kothari BRD	Director/Board Member	69	31/03/2014
Monjori Mitra BRD	Director/Board Member	64	24/08/2020

More insiders

Albert David Limited is an India-based pharmaceutical company. The Company's principal business is manufacturing and trading of pharmaceutical formulations, infusion solutions, herbal dosage forms and bulk drugs by way of domestic sale or export. Its product categories include formulations and bulk drugs. Its product range includes Placentrex range, Anaflam range and BREAZE range. Its formulations include parenteral, oral/enteral, topical agents and vision care. Its parenteral categories include amino acids infusion, anti-microbial, anti-leishmaniasis (kalazar), haemostat (inj), lvp, neurotropic vitamin and placenta extract. The Company's oral/enteral categories include amino acids oral, anthelmintic, anti-microbial, anti-ulcer ants, anti-vertigo, appetite stimulants, anti-tubercular, expectorant / cough syrup, hematinic, haemostat, hepato protective (ayurveda) and hepato protective (others). Its vision care categories include anti glaucoma, anti-infective and NSAID.

Employees

1,476

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
02/26/02	₹872.05	+0.04%	3,742
01/26/01	₹871.70	-2.92%	7,074
31/26/31	₹897.90	-0.08%	14,450
28/26/28	₹898.60	+0.94%	20,164
27/26/27	₹890.25	+2.36%	8,084

Delayed Quote NSE India S.E.

More quotes

As early as today, start finding the best investment opportunities!

1 day	+0.04%
1 week	+0.27%
Current month	-2.88%
1 month	+25.92%
3 months	+21.89%
6 months	+27.02%
Current year	+18.39%

1 week	861	931.85
1 month	685.55	931.85
Current year	579.9	931.85
1 year	579.9	931.85
3 years	579.9	1,753.95
5 years	486.85	1,753.95
10 years	263	1,753.95

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ALBERT DAVID LIMITED	+0.04%	+0.27%	-	-	5.23Cr
SUN PHARMACEUTICAL INDUSTRIES LTD.	+0.16%	+1.73%	+23.46%	+74.26%	4.88TCr
OTSUKA HOLDINGS CO., LTD.	-1.61%	-0.29%	+51.58%	+118.38%	4.07TCr
ZYDUS LIFESCIENCES LIMITED	-1.02%	+0.49%	+16.01%	+86.24%	1.23TCr
CIPLA LIMITED	-0.84%	+0.61%	-10.06%	+13.92%	1.21TCr
KRKA, D. D.	+0.57%	+1.73%	+31.59%	+153.11%	928.38Cr
GEDEON RICHTER	-1.53%	-2.86%	+24.35%	+44.68%	755.42Cr
GLENMARK PHARMACEUTICALS LIMITED	-0.23%	+0.94%	+28.27%	+223.22%	734.57Cr
ONO PHARMACEUTICAL CO., LTD.	-0.62%	-0.84%	+44.70%	-11.26%	729.62Cr
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-0.13%	-0.16%	-40.47%	+15.85%	525.5Cr
Average	-0.52%	+1.04%	+18.83%	+79.82%	1.67TCr
Weighted average by Cap.	-0.62%	+1.25%	+27.33%	+86.76%

	2025	2026
Net sales	345.77Cr 3.64Cr 3.14Cr 2.96Cr 2.69Cr 5.06Cr 5.09Cr 35Cr 14Cr 175.89Cr 14Cr 13Cr 583.2Cr	333.6Cr 3.52Cr 3.03Cr 2.85Cr 2.6Cr 4.89Cr 4.91Cr 34Cr 13Cr 169.69Cr 13Cr 13Cr 562.68Cr
Net income	17Cr 18.12L 15.63L 14.71L 13.4L 25.19L 25.33L 1.74Cr 67.67L 8.75Cr 68.05L 66.57L 29Cr	-1.49Cr -2L -1L -1L -1L -2L -2L -15.11L -6L -76.03L -6L -6L -2.52Cr
Net Debt	-231.34Cr -2.44Cr -2.1Cr -1.98Cr -1.8Cr -3.39Cr -3.41Cr -23Cr -9.1Cr -117.68Cr -9.15Cr -8.95Cr -390.2Cr	-228Cr -2.4Cr -2.07Cr -1.95Cr -1.78Cr -3.34Cr -3.36Cr -23Cr -8.97Cr -115.98Cr -9.02Cr -8.82Cr -384.57Cr

Albert David Limited Share Price NSE India S.E.

Stocks

ALBERTDAVD

INE155C01010

Pharmaceuticals

Valuation : Albert David Limited

Chart: Albert David Limited

Latest news : Albert David Limited

Quotes and Performance

Price Extremes

Managers and Directors : Albert David Limited

Generic Pharmaceuticals

Financials

Company Profile

Quotes